The capture antibody anchors the assay’s spatial resolution: molecules released by a cell are retained close to that cell on the coated membrane rather than dispersing through the culture. A labeled detection antibody then reveals these localized capture events. This arrangement makes secretory activity visible as discrete signals suitable for counting.
Spot enumeration provides a frequency-based readout rather than only a bulk measurement of total secreted material. Because signals remain associated with localized secretion events, the assay can identify how many cells responded within the tested population. This single-cell perspective is especially useful when a response is present in only a small fraction of cells.
The measured target determines which immune response is profiled. By detecting a secreted cytokine or antibody, Elispot Analysis can support evaluation of antigen-specific T-cell or B-cell responses in studies of infection and vaccination. This target-specific design also makes the assay useful for immune monitoring, where response type matters alongside responding-cell frequency.
A basic workflow starts by placing cells onto a membrane coated with a capture antibody and culturing them so secreted molecules bind nearby. After secretion, labeled antibodies detect the captured material, producing visible spots. The resulting spot pattern can then be interpreted as evidence of responding cells and compared across experimental immune conditions.
Elispot Analysis is useful when investigators need to detect antigen-specific responses with high sensitivity and single-cell resolution. In infection studies, it can evaluate host responses to pathogen exposure; in vaccination studies, it can assess vaccine-associated immune responses. The same readout also supports immune monitoring when response magnitude or responding-cell frequency is important.
Results can indicate whether a tested population contains cells that respond to a defined antigen by secreting the measured cytokine or antibody. This supports comparisons of host immunity across infection or vaccination settings and can extend to therapeutic-response monitoring. Interpretation should focus on responding-cell frequency represented by spots, while the secreted target identifies response type.